Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Novel Type of Prodrug Activation through a Long-Range O,N-Acyl Transfer: A Case of Water-Soluble CREB Inhibitor.

Li BX, Xie F, Fan Q, Barnhart KM, Moore CE, Rheingold AL, Xiao X.

ACS Med Chem Lett. 2014 Aug 22;5(10):1104-9. doi: 10.1021/ml500330n. eCollection 2014 Oct 9.

2.

Novel LHRH-receptor-targeted cytolytic peptide, EP-100: first-in-human phase I study in patients with advanced LHRH-receptor-expressing solid tumors.

Curtis KK, Sarantopoulos J, Northfelt DW, Weiss GJ, Barnhart KM, Whisnant JK, Leuschner C, Alila H, Borad MJ, Ramanathan RK.

Cancer Chemother Pharmacol. 2014 May;73(5):931-41. doi: 10.1007/s00280-014-2424-x. Epub 2014 Mar 8.

3.

Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo.

Baccaglini L, Shamsul Hoque AT, Wellner RB, Goldsmith CM, Redman RS, Sankar V, Kingman A, Barnhart KM, Wheeler CJ, Baum BJ.

J Gene Med. 2001 Jan-Feb;3(1):82-90.

PMID:
11269339
4.

Sodium phosphate enhances plasmid DNA expression in vivo.

Hartikka J, Bozoukova V, Jones D, Mahajan R, Wloch MK, Sawdey M, Buchner C, Sukhu L, Barnhart KM, Abai AM, Meek J, Shen N, Manthorpe M.

Gene Ther. 2000 Jul;7(14):1171-82.

5.

Insulin delivery with plasmid DNA.

Abai AM, Hobart PM, Barnhart KM.

Hum Gene Ther. 1999 Nov 1;10(16):2637-49.

PMID:
10566891
6.

Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice.

Horton HM, Hernandez P, Parker SE, Barnhart KM.

Cancer Res. 1999 Aug 15;59(16):4064-8.

7.

Simplified PCR-mediated, linker-scanning mutagenesis.

Barnhart KM.

Biotechniques. 1999 Apr;26(4):624-6. No abstract available.

8.

CpG motifs as immune adjuvants.

Klinman DM, Barnhart KM, Conover J.

Vaccine. 1999 Jan;17(1):19-25.

PMID:
10078603
9.
10.

A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.

Horton HM, Anderson D, Hernandez P, Barnhart KM, Norman JA, Parker SE.

Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1553-8.

11.

Enhancer and promoter chimeras in plasmids designed for intramuscular injection: a comparative in vivo and in vitro study.

Barnhart KM, Hartikka J, Manthorpe M, Norman J, Hobart P.

Hum Gene Ther. 1998 Nov 20;9(17):2545-53.

PMID:
9853521
12.

Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.

Saffran DC, Horton HM, Yankauckas MA, Anderson D, Barnhart KM, Abai AM, Hobart P, Manthorpe M, Norman JA, Parker SE.

Cancer Gene Ther. 1998 Sep-Oct;5(5):321-30.

PMID:
9824052
13.

Lipid- and adenoviral-mediated gene transfer into AIDS-Kaposi's sarcoma cell lines.

Campain JA, Matassa AA, Felgner PL, Barnhart KM, Curiel DT, Harrison GS.

Cancer Gene Ther. 1998 May-Jun;5(3):131-43.

PMID:
9622096
15.

The sequence of a murine cDNA encoding Ear-2, a nuclear orphan receptor.

Barnhart KM, Mellon PL.

Gene. 1994 May 16;142(2):313-4.

PMID:
8194772
16.

Helix-loop-helix proteins are present and differentially expressed in different cell lines from the anterior pituitary.

Jackson SM, Barnhart KM, Mellon PL, Gutierrez-Hartmann A, Hoeffler JP.

Mol Cell Endocrinol. 1993 Oct;96(1-2):167-76.

PMID:
8276132
17.
18.

Promoter elements and erythroid cell nuclear factors that regulate alpha-globin gene transcription in vitro.

Kim CG, Swendeman SL, Barnhart KM, Sheffery M.

Mol Cell Biol. 1990 Nov;10(11):5958-66.

19.
20.

Purification of four erythroid cell proteins that bind the promoters of the murine globin genes.

Sheffery M, Kim CG, Barnhart KM.

Prog Clin Biol Res. 1989;316A:343-57. No abstract available.

PMID:
2594815
21.
22.
23.

Cisplatin as an initiating agent in two-stage mouse skin carcinogenesis.

Barnhart KM, Bowden GT.

Cancer Lett. 1985 Oct;29(1):101-5.

PMID:
4063955

Supplemental Content

Loading ...
Support Center